Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fallopian tube pericytes
- Development stage
- Preclinical
- Lead developer
- Juvenescence
- Modality
- Cell Therapies
- Administration
- Intraperitoneal
01
Overview
Fallopian tube pericytes are a type of human pericyte derived from fallopian tube tissue. These cells, like other mesenchymal stem cells (MSCs), have been investigated for their potential regenerative capacity and immune-privileged properties in the context of Duchenne muscular dystrophy (DMD). In a preclinical study involving a murine model of DMD, fallopian tube pericytes were administered via weekly intraperitoneal injections over 8 weeks to evaluate their impact on motor ability and lifespan. However, this specific study found that fallopian tube pericytes did not significantly increase the lifespan of the affected mice, unlike adipose tissue-derived pericytes.
Beyond the preview
Go deeper on fallopian tube pericytes.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fallopian tube pericytes.